Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2− MBC in the real world

2023
Kruse M, Smyth EN, Bowman L, Gautam S, Guimaraes CM, Nisbett AR, Fisher MD, Cui ZL, Sheffield KM, Kalinsky K
Read more